Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis
Ernst HundDepartment of Neurology, University of Heidelberg, Heidelberg, GermanyAbstract: Transthyretin familial amyloid polyneuropathy (TTR-FAP) is a fatal clinical disorder characterized by extracellular deposition of abnormal fibrils derived from misfolded, normally soluble transthyretin (TTR) mo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-06-01
|
| Series: | The Application of Clinical Genetics |
| Online Access: | http://www.dovepress.com/familial-amyloidotic-polyneuropathy-current-and-emerging-treatment-opt-a10151 |